Clinical Trials
Clinical trials are research studies that are conducted in human subjects to evaluate new ways to prevent, detect, treat, or manage cancer or other diseases. Through clinical trials, researchers are able to determine whether or not new treatments, such as drugs, procedures, or medical devices, are safe and effective, and whether or not they work better than current treatments. Learning more about clinical trials can help you make an informed decision about whether or not to participate in one as part of your colorectal cancer treatment.
Possible Benefits of Participating in a Clinical Trial
If you have a disease such as colorectal cancer, there could be personal benefits such as:
A potential early access to a new treatment with positive results; the treatment may cure or control your condition or improve your quality of life; you may receive more expert medical care from the research teams involved in the clinical trial.
In addition, participating in a clinical trial can help others by advancing medical research.
Possible Benefits of Participating in a Clinical Trial

If you have a disease such as colorectal cancer, there could be personal benefits such as:
A potential early access to a new treatment with positive results; the treatment may cure or control your condition or improve your quality of life; you may receive more expert medical care from the research teams involved in the clinical trial.
In addition, participating in a clinical trial can help others by advancing medical research.
Possible Risks of Participating in a Clinical Trial
Because clinical trials often compare a new drug to an approved drug or combination of drugs that are part of the current standard of care, you may not always receive a new treatment. Even if you get a new drug, it may not help you. It may be less effective than the standard of care. As with any treatment, there is the risk of serious short- or long-term side effects.
Reducing Your Risk
Before you participate in a clinical trial, it is very important that you understand what is involved and give your informed consent. Talk to your doctor to best understand the risks and benefits so you can make an informed choice about participating.
Types of Clinical Trials
This type of trial looks at whether a particular treatment can help prevent cancer. These trials can be conducted in the general population or in people who have a higher than normal risk of developing a certain type of cancer, such as those with a family history of the disease.
Screening trials involve testing people for early signs of cancer before they have symptoms. These trials can be done in the general population or in a group of people who are at higher than normal risk of developing cancer. Screening trials may look at the effectiveness of a new screening test compared to standard tests.
Treatment trials are conducted in stages or phases. In trials that compare two or more treatments, participants are randomly assigned to a specific treatment group. Randomized trials give researchers the most reliable information about how well a new treatment works.
Types of Clinical Trials
Finding the Right Clinical Trial
Talk to your healthcare team to find out if participating in a clinical trial is right for you. You can also access the clinical trial databases below or contact a clinical trial navigator to learn more and find trials specific to your needs and location.
Clinical Trial Navigator Services in Canada
Canadian Cancer Clinical Trials Network
Clinical Trials Navigator provided by the Windsor Regional Hospital
The Clinical Trials Navigator is designed to help cancer patients search for and connect with clinical trials for which they may be eligible. The patient begins by completing an informed consent form, or their physician can complete a referral form. The patient is connected to the Clinical Trials Navigator, which helps them search for all eligible trials.
Contact the Clinical Trials Navigator at clinicaltrialsnavigator@wrh.on.ca;
P: (519) 253-3191 ext. 58583
Additional Clinical Trials Resources
Microplastics in the Gut Linked to Colorectal Cancer-Like Patterns
November 2025 New research from the microONE project (CBmed GmbH, Austria) suggests that microplastics may impact gut health by altering the microbiome. Using human stool samples to create controlled gut cultures, researchers exposed the samples...
Rectal Bleeding Identified as Key Predictor of Early-Onset Colorectal Cancer
November 2025 A recent study presented at the American College of Surgeons Clinical Congress 2025 highlights rectal bleeding as a strong predictor of early-onset colorectal cancer (EOCRC) in individuals under 50. Conducted by Jin et...
Do GLP-1 Medications Affect Cancer Risk?
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications, originally developed for the management of type 2 diabetes, has surged in recent years due to the approval for expanded use for chronic weight...
New study shows how the microbiome can impact the effectiveness of immunotherapy treatment
Researchers have discovered a new type of gut bacteria, called YB328, that may help cancer treatments work better. This bacterium was found in patients with lung and stomach cancers who responded well to a type...
Adjusting Oxaliplatin-based Chemotherapy Doses May Help Reduce Nerve Damage in Colon Cancer Treatment
A recent French study suggests that tailoring chemotherapy doses based on lean body mass (LBM), rather than standard body surface area, can reduce nerve-related side effects in people being treated for stage III colon cancer. ...
Promising New First-Line Treatment for BRAF V600E–Mutated Metastatic Colorectal Cancer
Updated results from the international BREAKWATER phase III trial show that patients with BRAF V600E-mutated metastatic colorectal cancer may live significantly longer when treated with a combination of encorafenib, cetuximab, and mFOLFOX6 chemotherapy, compared to...








































